Daré Bioscience, Inc.
Daré Bioscience, Inc. (DARE) Stock Overview
Explore Daré Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
21.4M
P/E Ratio
-12.49
EPS (TTM)
$-0.17
ROE
0.47%
DARE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Daré Bioscience, Inc. (DARE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.40.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.49 and a market capitalization of 21.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.